Older patients and patients of sub-Saharan African origin were at an increased risk of late presentation of advanced HIV. Late presentation of advanced HIV is most common in patients of older age and ...
GSK hosted an analyst presentation on its HIV segment (close to 20% of total sales) signaling increased focus on developing longer-duration therapies. While the updates don’t have an impact on our ...
In a recent study published in The Lancet, researchers assessed the incidence of mpox in individuals with advanced human immunodeficiency virus (HIV) infection. In July 2022, the World Health ...
Effective control of the spread of HIV depends on using the right antiretroviral drugs. In 2019, the World Health Organization recommended using the integrase inhibitor, dolutegravir (DTG), in first- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results